MCL
We also assessed mTOR signaling in MCL tumors using immunohistochemical methods and a tissue microarray: 10 of 30 (33%) expressed Ser473p-AKT, 13 of 21 (62%) Ser2448p-mTOR, 22 of 22 (100%) p-p70S6K, and 5 of 20 (25%) p-ribosomal protein S6.
We also assessed mTOR signaling in <span class="disease" id="17148679-8-35-38">MCL</span> tumors using immunohistochemical methods and a tissue microarray: 10 of 30 (33%) expressed Ser473p-AKT, 13 of 21 (62%) Ser2448p-<span class="gene" id="17148679-8-167-171">mTOR</span>, 22 of 22 (100%) p-p70S6K, and 5 of 20 (25%) p-ribosomal protein S6.